Bernhard Kirschbaum

Bernhard Kirschbaum, Ph.D., studied and spent his early career as a researcher in biochemistry and physiological chemistry at the University of Konstanz, Germany, receiving his Ph.D. in 1989. He moved on to work at the Rockefeller University in New York and the Pasteur Institute in Paris. Subsequently, he joined the pharmaceutical industry where he covered a broad range of technological and disease areas. Before joining various biotech companies as chairman and board member, respectively, he was head of Global Research and Early Development at Merck Serono. In this role, he was a member of the Pharmaceutical Executive Committee. Prior to joining Merck KGaA in 2005, he was Vice President Discovery Research, Global Head of Therapeutic Domains “Thrombosis & Angiogenesis” for Sanofi-Aventis. He also worked for Aventis, Hoechst Marion Roussel in various senior positions.